Kathleen A. Phillips
Kaiser Permanente
7 Papers
70 Citations
Kathleen A. Phillips is an academic researcher from Kaiser Permanente. The author has contributed to research in topics: Atrial fibrillation & Stroke. The author has an hindex of 7, co-authored 7 publications.
Chat about Author
Papers
Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.
Alan S. Go,Elaine M. Hylek,Kathleen A. Phillips,Yuchiao Chang,Lori E. Henault,Joe V. Selby,Daniel E. Singer +6 more
TL;DR: It is confirmed that atrial fibrillation is common among older adults and provides a contemporary basis for estimates of prevalence in the United States.
6.6K
Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
Alan S. Go,Elaine M. Hylek,Yuchiao Chang,Kathleen A. Phillips,Lori E. Henault,Angela M. Capra,Nancy G. Jensvold,Joe V. Selby,Daniel E. Singer +8 more
TL;DR: Warfarin is very effective for preventing ischemic stroke in patients with atrial fibrillation in clinical practice while the absolute increase in the risk of intracranial hemorrhage is small.
713
Warfarin Use among Ambulatory Patients with Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
Alan S. Go,Elaine M. Hylek,Leila H. Borowsky,Kathleen A. Phillips,Joe V. Selby,Daniel E. Singer +5 more
TL;DR: A large, contemporary sample of ambulatory patients with nonvalvular atrial fibrillation treated in a health maintenance organization was assembled and the prevalence and determinants of warfarin use for stroke prevention were assessed.
637
Implications of Stroke Risk Criteria on the Anticoagulation Decision in Nonvalvular Atrial Fibrillation The Anticoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study
Alan S. Go,Elaine M. Hylek,Kathleen A. Phillips,Leila H. Borowsky,Lori E. Henault,Yuchiao Chang,Joe V. Selby,Daniel E. Singer +7 more
TL;DR: Large, prospective studies with many stroke events are needed to precisely determine the relationship of age to stroke risk in AF and to identify which AF subgroups are at a sufficiently low stroke risk to forego anticoagulation.
218
Factor V Leiden and risk of ischemic stroke in nonvalvular atrial fibrillation: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.
Alan S. Go,Alan S. Go,Guy L. Reed,Elaine M. Hylek,Kathleen A. Phillips,Lin Liu,Lori E Henault,Joe V. Selby,Daniel E. Singer +8 more
TL;DR: Within a large nested case-control sample of patients with atrial fibrillation, factor V Leiden was not significantly associated with risk of stroke, however, given the suggestive nature of the findings, further study in even larger numbers of patients is needed.
38